Compare MPWR & VEEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MPWR | VEEV |
|---|---|---|
| Founded | 1997 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Computer Software: Prepackaged Software |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.9B | 36.9B |
| IPO Year | 2004 | 2013 |
| Metric | MPWR | VEEV |
|---|---|---|
| Price | $1,077.85 | $224.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 26 |
| Target Price | ★ $1,016.56 | $303.52 |
| AVG Volume (30 Days) | 477.6K | ★ 1.5M |
| Earning Date | 02-05-2026 | 03-04-2026 |
| Dividend Yield | ★ 0.58% | N/A |
| EPS Growth | ★ 343.79 | 26.69 |
| EPS | ★ 39.37 | 5.13 |
| Revenue | $2,660,969,000.00 | ★ $3,080,246,000.00 |
| Revenue This Year | $28.40 | $17.74 |
| Revenue Next Year | $16.87 | $12.28 |
| P/E Ratio | ★ $27.30 | $42.83 |
| Revenue Growth | ★ 30.48 | 15.96 |
| 52 Week Low | $438.86 | $201.54 |
| 52 Week High | $1,123.38 | $310.50 |
| Indicator | MPWR | VEEV |
|---|---|---|
| Relative Strength Index (RSI) | 71.18 | 45.16 |
| Support Level | $1,008.50 | $215.55 |
| Resistance Level | $1,004.74 | $226.64 |
| Average True Range (ATR) | 34.47 | 7.13 |
| MACD | 12.49 | 0.15 |
| Stochastic Oscillator | 85.55 | 29.38 |
Monolithic Power Systems is an analog and mixed-signal chipmaker specializing in power management solutions. Its mission is to reduce total energy consumption in end systems. It serves the computing, automotive, industrial, communications, and consumer end markets. MPS uses a fabless manufacturing model, partnering with third-party chip foundries to host its proprietary BCD process technology.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.